首页> 外文期刊>Bulletin of experimental biology and medicine >Cardiotoxic and Dyslipidemic Effects of Doxorubicin and Betulinic Acid Amide
【24h】

Cardiotoxic and Dyslipidemic Effects of Doxorubicin and Betulinic Acid Amide

机译:多柔比星和桦木酸酰胺的心脏毒害和渗透性作用

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Changes in the blood lipid spectrum and structural reorganization of the rat myocardium in response to injection of a single sublethal dose of doxorubicin (7 mg/kg) alone and in combination with course administration of betulonic acid amide (100 mg/kg/day for 14 days) were studied. Betulinic acid amide in the specified dose exhibited less pronounced cardiotoxic (necrobiotic impairment of cardiomyocytes) and dyslipidemic (increase of cholesterol and triglyceride levels) effects in comparison with doxorubicin. Combined treatment with betulinic acid amide and doxorubicin led to more pronounced remodeling of the myocardium, which was shown by a significant increase of the connective tissue/cardiomyocyte volume ratio detected by day 14 of the experiment.
机译:响应于单独注射单次核酸剂(7mg / kg)的单次核酸剂量(7mg / kg)的血脂谱和大鼠心肌的结构重组的变化,并与甲状腺酸酰胺的课程给药(100mg / kg /天14 几天)是研究过的。 与多柔比星相比,指定剂量中的桦木酸酰胺表现出较少明显的心脏毒性(丧失心肌损伤)和渗透血症(胆固醇和甘油三酯水平的增加)的影响。 用乙炔酸酰胺和多柔比星的组合处理导致心肌的更明显的重塑,其通过实验第14天检测到的结缔组织/心肌细胞体积比显着增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号